R&D-to-Revenue Ratio

The percentage of a company's sales that is reinvested into research and development to drive future innovation.

The R&D-to-Revenue ratio (also known as R&D intensity) measures a company's commitment to innovation by showing the percentage of its top-line sales that is reinvested into research and development. It is a vital metric for evaluating companies in high-growth, technology-driven sectors like biotechnology, software, and semiconductors, where continuous innovation is required to survive. To calculate the ratio, an investor divides a company's total R&D expenses by its total revenue over the same period, usually a fiscal year or quarter. Both figures are easily located on the GAAP income statement. Because R&D is expensed immediately rather than capitalized, this metric directly reflects current-period spending choices. For investors, a high ratio indicates a strong focus on building a competitive moat and driving long-term organic growth. However, extremely high R&D spending can depress current operating margins and short-term profitability. Investors must assess whether this heavy spending is translating into successful product launches and market share gains, or if it represents inefficient spending that fails to generate a high return on investment.

Company A generates $100,000,000 in total revenue and spends $15,000,000 on research and development during the same fiscal year. Its R&D-to-Revenue ratio is calculated as $15,000,000 / $100,000,000 = 0.15, or 15%.